Last reviewed · How we verify

minor throat irritation — Treatment Landscape & Competitive Intelligence

minor throat irritation (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating minor throat irritation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Formula 3 Cough Syrup SYRUP Vitality Works, Inc.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Vitality Works, Inc. · 1 drug in minor throat irritation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in minor throat irritation:

Cite this brief

Drug Landscape (2026). minor throat irritation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/minor-throat-irritation. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing